Clinical Trial: Carfilzomib, Oral Cyclophosphamide, and Dexamethasone for RRMM
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: Multiple Myeloma in Relapse
Study Type: INTERVENTIONAL
Official Title: A Phase II Study of Carfilzomib, Oral Cyclophosphamide, and Dexamethasone for Relapsed and/or Refractory Multiple Myeloma
Brief Summary:
This study aims to study the efficacy and safety of oral cyclophosphamide in addition to carfilzomib and dexamethadone for RRMM patients who have been previously exposed to lenalidomide combination therapies.
Read more